Targeting cardiovascular risk: Early identification of insulin resistance

Journal of the American Academy of Nurse Practitioners

Volumn 20, Issue 6, 2008, Pages 319-325

  Fortson, Julie ^a   Howe, Linda ^b   Harmon, Corinne ^b   Sherrill, Windsor Westbrook ^c  

^a Carolina Cardiology Consultants PA   (United States)

^b CLEMSON UNIVERSITY   (United States)

^c CLEMSON UNIVERSITY   (United States)

Author keywords

Cardiovascular risk; Insulin resistance; Metabolic syndrome; Review

Indexed keywords

CARDIOVASCULAR DISEASE; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK ASSESSMENT; TIME;

CARDIOVASCULAR DISEASES; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; RISK ASSESSMENT; TIME FACTORS;

EID: 45249123205     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2008.00324.x     Document Type: Review

References (27)

1. American College of Endocrinology 2003). American College of Endocrinology position statement on the insulin resistant syndrome. Endocrine Practice, 9, 240 252.
2. American Diabetes Association 2005). ADA: Diabetes facts and figures, 2005. Retrieved June 2, 2006, from http://www.diabetes.org
3. American Diabetes Association 2006). ADA: Diabetes facts and figures, 2006. Retrieved June 11, 2006, from http://www.diabetes.org
4. American Heart Association 2006). Heart disease and stroke statistics - 2006 update. Circulation, 113, e85 e151.
5. American Heart Association 2007). Heart disease and stroke statistics - 2007 update. Dallas, TX : Author.
6. Andersen, L., Boreham, C., Young, I., Davey Smith, G., Gallagher, A., Murray, L. McCarron, P 2006). Insulin sensitivity and clustering of coronary heart disease risk factors in young adults: The Northern Ireland Young Hearts Study [Abstract]. Preventive Medicine, 42, 73.
7. Appel, S. J 2005). Calculating insulin resistance in the primary care setting: Why should we worry about insulin levels in euglycemic patients? Journal of the American Academy of Nurse Practitioners, 17, 331 336.
8. Boyko, E., Leonetti, D., Bergstrom, R., Newell-Morris, L. Fujimoto, W 1996). Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity: Five-year follow-up among initially nondiabetic Japanese-American men. Diabetes, 45, 1010 1015.
9. Cordain, L., Eades, M. Eades, M 2003). Hyperinsulinemic diseases of civilization: More than just Syndrome X. Comparative Biochemistry and Physiology Part A, 136, 95 112.
10. Garvey, W., Kwon, S., Zheng, D., Shaughnessy, S., Wallace, P., Hutto, A., et al 2003). Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes, 52, 453 462.
11. Hanley, A., Williams, K., Stern, M. Haffner, S 2002). Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Heart Study. Diabetes Care, 25, 1177 1185.
12. Hsueh, W. Law, R 1999). Insulin signaling in the arterial wall. American Journal of Cardiology, 84, 21J 24J.
13. Hu, F., Stampfer, M., Haffner, S., Solomon, C., Willett, W. Manson, J 2002). Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care, 25, 1129 1134.
14. Jones, C., Abbasi, F., Carantoni, M., Polonsky, K. Reaven, G 2000). Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. American Journal of Physiology, Endocrinology, and Metabolism, 278, E501 E508.
15. Lebovitz, H 2006). Insulin resistance - A common link between type 2 diabetes and CVD. Diabetes, Obesity, and Metabolism, 8, 237 249.
16. Low Wang, C., Goalstone, M. Draznin, B 2004). Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes, 53, 2735 2740.
17. Malik, S., Wong, N., Franklin, S., Kamath, T., L'Italien, G., Pio, J., et al 2004). Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 110, 1245 1250.
18. Monzillo, L. Hamby, O 2003). Evaluation of insulin sensitivity in clinical practice and in research setting. Nutrition Reviews, 61, 397 412.
19. National Cholesterol Education Program 2001). Executive summary of the third report of the National Cholesterol Education Program Expert Panel on detection. Evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of American Medical Association, 285, 2486 2497.
20. Nilsson, P., Nilsson, J., Hedblad, B., Eriksson, K.-F. Berglund, G 2003). Hyperinsulinaemia as long-term predictor of death and ischaemic heart disease in nondiabetic men: The Malmo Preventive Project. Journal of Internal Medicine, 253, 136 145.
21. Pyorala, M., Miettinen, H., Laakso, M. Pyorala, K 1998). Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study. Circulation, 98, 398 404.
22. Reilly, M., Wolfe, M., Rhodes, T., Girman, C., Mehta, N. Rader, D 2004). Measures of insulin resistance add incremental value to the clinical diagnosis of metabolic syndrome in association with coronary atherosclerosis. Circulation, 110, 803 809.
23. Reinehr, T., de Sousa, G. Andler, W 2005). Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children. Obesity Research, 13, 1824 1833.
24. Ridker, P., Buring, J., Cook, N. Rifai, N 2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year-follow-up of 14,719 initially healthy American women. Circulation, 107, 391 397.
25. Stern, M 1995). Diabetes and cardiovascular disease: The "common soil" hypothesis. Diabetes, 44, 369 375.
26. Stern, M., Pugh, J., Gaskill, S. Hazuda, H 1982). Knowledge, attitudes, and behavior related to obesity and dieting in Mexican Americans and Anglos: The San Antonio Heart Study. American Journal of Epidemiology, 115, 917 928.
27. World Health Organization Consultation 1999). Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland : World Health Organization.